Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents-Reference-Cited by-同舟云学术

Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents

Published:1996-12 Issue:6 Volume:28 Page:855-860
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Roe Denise J.,Harford Antonia M.,Zager Philip G.,Wiltbank Thomas B.,Kirlin Linda,Valle Ann Marie Della,Van Wyck David B.

Publisher

Elsevier BV

Subject

Nephrology

Reference12 articles.

1. Epoetin and iron deficiency;Van Wyck,1993

2. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin;Wingard;Am J Kidney Dis,1995

3. Iron status in patients receiving erythropoietin for dialysis-associated anemia;Van Wyck;Kidney Int,1989

4. Characteristics of iron dextran utilization in man;Henderson;Blood,1969

5. Monitoring of iron requirements in renal patients on erythropoietin;Anastassiades;Nephrol Dial Transplant,1993

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and costs associated with anemic chronic kidney disease patients;CURR MED RES OPIN;2008

2. Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis;Transfusion;2007-10

3. Is There a Difference between the Allergic Potencies of the Iron Sucrose and Low Molecular Weight Iron Dextran?;Renal Failure;2007-01

4. Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis;Nephron Clinical Practice;2005-04-15

5. Structure, chemistry, and pharmacokinetics of intravenous iron agents;J AM SOC NEPHROL;2004